Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis - New Market Research Report
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different medicine products to improve patient's health such as predictive medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. Its commercial molecular diagnostic tests comprise BRACAnalysis, COLARIS, MELARIS, PANEXIA, OnDose, COLARIS AP, PREZEON, TheraGuide, TruCulture, DiscoveryMAP, Prolaris and RodentMap The company along with its subsidiaries operates in the US,...
View full press release